GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hangzhou Tigermed Consulting Co Ltd (SZSE:300347) » Definitions » EV-to-FCF

Hangzhou Tigermed Consulting Co (SZSE:300347) EV-to-FCF : 51.38 (As of Apr. 27, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Hangzhou Tigermed Consulting Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Hangzhou Tigermed Consulting Co's Enterprise Value is ¥42,991 Mil. Hangzhou Tigermed Consulting Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was ¥837 Mil. Therefore, Hangzhou Tigermed Consulting Co's EV-to-FCF for today is 51.38.

The historical rank and industry rank for Hangzhou Tigermed Consulting Co's EV-to-FCF or its related term are showing as below:

SZSE:300347' s EV-to-FCF Range Over the Past 10 Years
Min: -552.38   Med: 116.11   Max: 2198.62
Current: 46.83

During the past 13 years, the highest EV-to-FCF of Hangzhou Tigermed Consulting Co was 2198.62. The lowest was -552.38. And the median was 116.11.

SZSE:300347's EV-to-FCF is ranked worse than
76.7% of 103 companies
in the Medical Diagnostics & Research industry
Industry Median: 24.94 vs SZSE:300347: 46.83

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-27), Hangzhou Tigermed Consulting Co's stock price is ¥57.70. Hangzhou Tigermed Consulting Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ¥2.340. Therefore, Hangzhou Tigermed Consulting Co's PE Ratio for today is 24.66.


Hangzhou Tigermed Consulting Co EV-to-FCF Historical Data

The historical data trend for Hangzhou Tigermed Consulting Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Tigermed Consulting Co EV-to-FCF Chart

Hangzhou Tigermed Consulting Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 112.27 157.90 101.02 98.41 56.55

Hangzhou Tigermed Consulting Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 98.41 133.83 56.88 66.76 56.55

Competitive Comparison of Hangzhou Tigermed Consulting Co's EV-to-FCF

For the Diagnostics & Research subindustry, Hangzhou Tigermed Consulting Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hangzhou Tigermed Consulting Co's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Hangzhou Tigermed Consulting Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Hangzhou Tigermed Consulting Co's EV-to-FCF falls into.



Hangzhou Tigermed Consulting Co EV-to-FCF Calculation

Hangzhou Tigermed Consulting Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=42990.871/836.68
=51.38

Hangzhou Tigermed Consulting Co's current Enterprise Value is ¥42,991 Mil.
Hangzhou Tigermed Consulting Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥837 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hangzhou Tigermed Consulting Co  (SZSE:300347) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Hangzhou Tigermed Consulting Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=57.70/2.340
=24.66

Hangzhou Tigermed Consulting Co's share price for today is ¥57.70.
Hangzhou Tigermed Consulting Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2.340.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Hangzhou Tigermed Consulting Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Hangzhou Tigermed Consulting Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Hangzhou Tigermed Consulting Co (SZSE:300347) Business Description

Traded in Other Exchanges
Address
Block 8, No. 19 Jugong Road, Room 2001-2010, 20th Floor, Xixing Sub-District, Binjiang District, Hangzhou, CHN, 310053
Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.

Hangzhou Tigermed Consulting Co (SZSE:300347) Headlines

No Headlines